← SynDRA
RQ-00000004
SynDRA canonical compound SYN1952419 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ATP4A |
|---|
| Mechanism of action | h+/k+-atpase inhibitor |
|---|
| Indication | gastroesophageal reflux disease (gerd) |
|---|
| Disease area | gastroenterology |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- PF-03716556
- RQ-00000774
- RQ-4
- Acid pump inhibitor (GERD), Pfizer
- Acid pump inhibitor (GERD), RaQualia;Acid pump inhibitor (gastroesophageal reflux), Pfizer
- Acid pump inhibitor (gastroesophageal reflux), RaQualia
Look up RQ-00000004 in the interactive SynDRA portal →